Ataxia is a common problem in Parkinson’s disease (PD), and many early onset Alzheimer’s disease patients (AD) also deal with it. Now there is a non-invasive test for mouse models.
Alzheimer’s disease (AD) is a huge public health issue as it affects a large part of the aging population. Neuropathology is studied primarily in the end stages of the disease. What about prevention?
Prof. Dr. Berry M. Spruijt recently retired from his position at Utrecht University. I had the honor of attending the symposium that was organized to reflect on and celebrate his career.
Researchers use different ways to analyze gait in animals. In what instances would a study benefit from a system that is based on voluntary walking?
This blog post features 10 interesting studies that use innovative techniques to study models of AD and PD and important underlying neuronal mechanisms.
Xu Liu and colleagues recently investigated the effects of Ginkgo biloba extract on a mouse model for Alzheimer’s disease (AD).
Craving a snack, the joy of eating it. The part of our brain that regulates this is the lateral hypothalamus. An interesting targer for addiction and eating disorder research.
The number of children diagnosed with developmental disorders has increased exponentially in the past 20 yearschemicals such as BPA have been under investigation lately.
The treatment of Fragile X syndrome is limited to the symptoms. One of the factors currently holding back drug development is the difficulty of finding a reliable behavioral test for neurobiological studies.
These studies specifically investigate the long-term effects of L-DOPA or levopoda, a common clinical treatment for Parkinson's disease, with which many patients struggle.